ABH Healthcare SME IPO Opens Monday: Check Price Band, Fund Allocation, as Hospital Chain Targets Growth
ABH Healthcare Ltd., a growing multi-speciality provider, is set to begin its Initial Public Offering (IPO) on Monday. The public issue offers an opportunity for investors to participate in the listing of this rapidly expanding healthcare entity. The shares are slated for listing on the NSE SME platform Emerge starting September 1.Key Details of the ABH Healthcare IPO
The company is offering a fresh issue of up to 34.29 lakh equity shares, comprising a total share sale worth ₹34.98 crore. The price band for the issue has been fixed at ₹96 to ₹102 per share. Interested investors must complete their subscription by August 27.Currently, grey market activity indicates that the company's shares are trading at a flat Grade Market Premium (GMP). This provides transparency as retail and institutional buyers prepare for the offering launch.
Corporate Profile and Financial Performance
Established in 2021 under the brand name "Anil Baghi Hospital," ABH Healthcare operates a comprehensive 150-bed multi-speciality hospital. The facility offers services across 25 medical specialities.The hospital's operational reach is significantly broadened, as it is empanelled with 30 private and public health insurance providers and third party administrators. This wide network indicates strong industry acceptance of its services.
The company has shown robust financial strengthening over the past three years. Consolidated revenue saw a steady rise from ₹41.38 crore in FY24 to ₹52.51 crore by FY26. Furthermore, profit after tax increased more than threefold during the same period, climbing from ₹1.66 crore to ₹5.64 crore.
Fund Utilization and Future Growth Strategy
ABH Healthcare has outlined a clear utilization plan for the net proceeds raised through the IPO. The company plans to dedicate up to ₹17 crore towards debt repayment in part or full settlement. An additional ₹5 crore will be allocated to cover working capital requirements.The remaining funds from the issue are earmarked for inorganic growth, encompassing unidentified acquisitions and general corporate purposes. Saurabh Baghi, Managing Director at ABH Healthcare Ltd, stated that the company remains focused on enhancing patient care and strengthening its clinical capabilities as it embarks on this new journey as a listed entity.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.